Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates

Novavax (NVAX) came out with a quarterly loss of $1.05 per share versus the Zacks Consensus Estimate of a loss of$ 1.04. This compares to loss of $3.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -0.96%. A quarter ago, it was expected that this vaccine maker would post a loss of$ 0.49 per share when it actually produced a loss of $1.44, delivering a surprise of -193.88%.Over the last four quarters, the company has surpasse ...